Inventiva S.A.(IVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IVA Inventiva S.A.

Market Closed 12-20 16:00:00 EST

2.35

-0.02

-0.84%

盘后2.35

+0.000.00%

16:05 EST

High2.35	Low2.29	Vol2.53K
Open2.32	D1 Closing2.37	Amplitude2.72%
Mkt Cap204.63M	Tradable Cap57.96M	Total Shares87.08M
T/O5.85K	T/O Rate0.01%	Tradable Shares24.66M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"IVA","market":"US","secType":"STK","nameCN":"Inventiva S.A.","latestPrice":2.35,"timestamp":1734728400000,"preClose":2.37,"halted":0,"volume":2530,"hourTrading":{"tag":"盘后","latestPrice":2.35,"preClose":2.35,"latestTime":"16:05 EST","volume":4,"amount":9.4,"timestamp":1734728744715},"delay":0,"floatShares":24664826,"shares":87077695,"eps":-2.218419,"marketStatus":"Market Closed","change":-0.02,"latestTime":"12-20 16:00:00 EST","open":2.32,"high":2.35,"low":2.2856,"amount":5847.02405,"amplitude":0.027173,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.218419,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734944400000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1594353600000,"exchange":"NASDAQ","adjPreClose":2.37,"postHourTrading":{"tag":"盘后","latestPrice":2.35,"preClose":2.35,"latestTime":"16:05 EST","volume":4,"amount":9.4,"timestamp":1734728744715},"volumeRatio":0.22572356587922002},"requestUrl":"/m/hq/s/IVA","defaultTab":"news","newsList":[{"id":"2492918695","title":"Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2492918695","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492918695?lang=en_us&edition=fundamental","pubTime":"2024-12-18 05:00","pubTimestamp":1734469200,"startTime":"0","endTime":"0","summary":"Daix , New York City , December 17, 2024 – Inventiva  , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis , also known as non-alcoholic steatohepatitis , and other diseases with significant unmet medical needs, today announced that Frédéric Cren, CEO and cofounder of Inventiva, has been invited to present a corporate overview, and will engage, with Inventiva’s leadership team, in investor meetings at the upcoming 43rd Annual J.P. Morgan Annual Healthcare Conference, being held on January 13-16, 2025 at the Westin St. Francis in San Francisco, California.The Westin St. Francis Hotel, San Francisco, California. The Company has a scientific team of approximately 90 people with deep expertise in the fields of biology, medicinal and computational chemistry, pharmacokinetics and pharmacology, and clinical development. It owns an extensive library of approximately 240,000","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XY_QbwknG0g_dMiiDPyLvw--~B/aD0xNzg7dz0zNzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a1497e6e1366ecc45a71fef2ce2e7535","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XY_QbwknG0g_dMiiDPyLvw--~B/aD0xNzg7dz0zNzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a1497e6e1366ecc45a71fef2ce2e7535"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inventiva-present-43rd-annual-j-210000559.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4504","BK4588","LU0106261372.USD","LU1720051108.HKD","LU2271345857.HKD","BK4581","LU2089283258.USD","BK4137","LU2111349929.HKD","LU1989772923.USD","LU0314104364.USD","IE00BZ1G4Q59.USD","PST","LU2028103732.USD","BK4139","LU1720051017.SGD","LU0158827948.USD","LU1074936037.SGD","LU1668664300.SGD","BK4585","LU0098860793.USD","BK4127","LU1989772840.SGD","LU2023251221.USD","LU0006306889.USD","LU1162221912.USD","LU0267386448.USD","LU0320765646.SGD","LU2357305700.SGD","IVA","LU0106831901.USD","HCSG","LU0225283273.USD","LU1363072403.SGD","IE00BKVL7J92.USD","LU0971096721.USD","LU0158827781.USD","LU2089284900.SGD","BK4516","BK4534","LU1548497426.USD"],"gpt_icon":0},{"id":"2492628056","title":"Inventiva S.A. Boosts Capital with New Share and Warrant Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2492628056","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492628056?lang=en_us&edition=fundamental","pubTime":"2024-12-17 05:27","pubTimestamp":1734384432,"startTime":"0","endTime":"0","summary":"Inventiva ( ($IVA) ) has issued an update. Inventiva S.A. has announced a significant capital increase through the issuance of new ordinary shares ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inventiva-s-a-boosts-capital-with-new-share-and-warrant-issuance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inventiva-s-a-boosts-capital-with-new-share-and-warrant-issuance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2491969709","title":"Inventiva Splits CEO, Board Chairman Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2491969709","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491969709?lang=en_us&edition=fundamental","pubTime":"2024-12-16 23:00","pubTimestamp":1734361203,"startTime":"0","endTime":"0","summary":"Inventiva  said Monday its board has acknowledged the separation of the roles of the chairman and the chief executive.The company said Mark Pruzanski was appointed as the new board chairman, with Frederic Cren keeping the CEO position.Inventiva also said it secured 21.4 million euros  leading to completion of the first tranche of the 116-million-euro financing that is part of the multi-tranche equity financing of up to 348 million euros announced in October.Price: 2.45, Change: +0.03, Percent Change: +1.24","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2491365173","title":"Inventiva Secures EUR 21.4 Mln, Seals First Tranche Of Multi-Tranche Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2491365173","media":"T-Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491365173?lang=en_us&edition=fundamental","pubTime":"2024-12-16 15:59","pubTimestamp":1734335980,"startTime":"0","endTime":"0","summary":"Inventiva SA :Secures 21.4 Million And Completes The First Tranche Of The Previously Announced Multi-Tranche Financing  Of Up To 348 Million.Additional Cash Requirements Estimated At 120 Million To 130 Million.Proceeds To Advance Phase Iii Nativ3 Clinical Trial.Appoints Mark Pruzanski As Chairman And Srinivas Akkaraju To Board.Company Estimates Financing Operations Until Mid-Q3 2025.Net Proceeds Of 20.1 Million To Fund Clinical Program And Corporate Purposes.Board Approves Second Phase Of Tranche 1 For 21.4 Million.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2491655396","title":"Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing  of up to €348 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2491655396","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491655396?lang=en_us&edition=fundamental","pubTime":"2024-12-16 15:30","pubTimestamp":1734334200,"startTime":"0","endTime":"0","summary":"Inventiva secures 21.4 million leading to completion of the first tranche of the financing for c. 116 million, part of the multi-tranche equity financing of up to 348 million announced on October 14, 2024.Proceeds from the completed first tranche to be primarily used to advance Inventiva’s Phase III, NATiV3 clinical trial evaluating lanifibranor in patients with MASH.Appointment of Mark Pruzanski as new Chairman of the Board of Directors and Srinivas Akkaraju as new member of the Board of Directors.Following issuance of the T1 New Shares and T1 BSAs, and the subsequent adoption by shareholders of the appro","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XY_QbwknG0g_dMiiDPyLvw--~B/aD0xNzg7dz0zNzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a1497e6e1366ecc45a71fef2ce2e7535","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XY_QbwknG0g_dMiiDPyLvw--~B/aD0xNzg7dz0zNzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a1497e6e1366ecc45a71fef2ce2e7535"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inventiva-secures-21-4-million-073000352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BSA","BK4139","BK4156","NEA","IVA"],"gpt_icon":0},{"id":"2491354345","title":"Press Release: Results of the votes of the Combined Shareholders' General Meeting of December 11, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2491354345","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491354345?lang=en_us&edition=fundamental","pubTime":"2024-12-13 05:00","pubTimestamp":1734037200,"startTime":"0","endTime":"0","summary":"Daix , New York City , December 11, 2024 -- Inventiva  , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis , also known as non-alcoholic steatohepatitis , and other diseases with significant unmet medical needs, today announced the results of the votes of its Combined Shareholders' Meeting.The Combined Shareholders' Meeting was held on Wednesday December 11, 2024, at 9 a.m. at Htel Oceania Le Jura, 14 avenue Foch, 21000 Dijon , under the chairmanship of Mr. Frédéric Cren, Chairman and Chief Executive Officer and cofounder of Inventiva.Mr. Frederic Cren proceeded to the usual formalities of the opening of the meeting, in particular to the constitution of the Bureau by appointing Mr. Pierre Broqua and Mr. Jean Volatier, as tellers, as well as Mr. Eric Duranson, as secretary of the general meeting.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2488198953","title":"Verint Systems Inc. (VRNT): Transforming Customer Experience with AI-Powered Automation and Intelligent Voice Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2488198953","media":"Insider Monkey","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488198953?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:21","pubTimestamp":1733314915,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Small Cap AI Stocks To Buy According to Hedge Funds.In this article, we are going to take a look at where Verint Systems Inc.  stands against the other small cap AI stocks.Former House Speaker Kevin McCarthy joined CNBC's 'Squawk Box' on November 26 where he emphasized the need for a new group he has created, the Alpha Institute, which aims to advocate for pro-technology proposals. He highlighted the importance of focusing on long-term technological advancements, particularly in AI and quantum technology, which he believes are critical for America's future competitiveness.McCarthy noted that legislators often become bogged down in daily issues and fail to consider the long-term implications of their policies. He shared that three years ago, he initiated a course to educate members of Congress on AI and quantum technologies, recognizing their significance in various sectors such as energy and defense. He argued that without reforming processes ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1IA5D3fr9KHMV9XeAelegQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/034484968a17b417afb2d104b7fb01fe","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1IA5D3fr9KHMV9XeAelegQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/034484968a17b417afb2d104b7fb01fe"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/verint-systems-inc-vrnt-transforming-122155856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1559883803.SGD","QLD","TQQQ","MNQmain","BK4023","SQQQ",".IXIC","LU0566484027.USD","QID","IVA","VRNT","NQmain","BK4139","PSQ"],"gpt_icon":1},{"id":"2487564904","title":"Verint Systems Inc. (VRNT) Rallies with Strong AI Performance, Secures Key Contracts and Market Leadership Recognition","url":"https://stock-news.laohu8.com/highlight/detail?id=2487564904","media":"Insider Monkey","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487564904?lang=en_us&edition=fundamental","pubTime":"2024-11-30 00:29","pubTimestamp":1732897775,"startTime":"0","endTime":"0","summary":"In an interview with CNBC on November 25, Dan Ives, Global Head of Technology Research at Wedbush Securities said that he sees the AI sector entering a new phase, describing it as the start of a \"fourth industrial revolution.\" He believes the AI market is still in its early stages but will continue to grow rapidly. Ives highlighted software companies, which he believes will be key players in AI's future, especially by 2025.Apart from a handful of skeptics, most experts and analysts see AI as the most revolutionary technology of the 21st century. There has also been a rise in AI startups. According to a June report by Morgan Stanley, the tech IPO market is picking up after a two-year pause. High interest rates had previously dampened IPO activity, but demand is returning, especially for companies using AI to improve business operations or customer experiences. While challenges like high capital costs remain, the AI-driven growth in tech and healthcare sectors is fueling the IPO revival.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1IA5D3fr9KHMV9XeAelegQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/034484968a17b417afb2d104b7fb01fe","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1IA5D3fr9KHMV9XeAelegQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/034484968a17b417afb2d104b7fb01fe"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/verint-systems-inc-vrnt-rallies-162935145.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765646.SGD","SQQQ","VRNT","LU1720051017.SGD","LU0158827781.USD","LU0314104364.USD","LU1720051108.HKD","LU2357305700.SGD","IVA","LU1668664300.SGD","BK4023","BK4127","LU0225283273.USD",".IXIC","LU1074936037.SGD","BK4139","IE00BZ1G4Q59.USD","TQQQ","LU2023251221.USD","BK4504","LU1989772840.SGD","LU1989772923.USD","LU0098860793.USD","LU0158827948.USD","QID","LU1559883803.SGD","NQmain","LU0267386448.USD","LU0106261372.USD","LU2271345857.HKD","IE00BKVL7J92.USD","MNQmain","BK4516","LU1363072403.SGD","LU2028103732.USD","LU0566484027.USD","PSQ","LU0006306889.USD","LU1162221912.USD","BK4534","LU2089283258.USD","QLD","BK4581","LU2089284900.SGD","BK4585","BK4588","LU0106831901.USD","LU0971096721.USD","LU2111349929.HKD"],"gpt_icon":1},{"id":"2486832036","title":"Inventiva Plans Strategic Moves at Upcoming 2024 Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2486832036","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486832036?lang=en_us&edition=fundamental","pubTime":"2024-11-27 05:31","pubTimestamp":1732656712,"startTime":"0","endTime":"0","summary":"Inventiva (IVA) has released an update. Inventiva has announced its upcoming general meeting on December 11, 2024, where shareholders will vote on ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inventiva-plans-strategic-moves-at-upcoming-2024-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inventiva-plans-strategic-moves-at-upcoming-2024-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2485625552","title":"Inventiva Is Maintained at Buy by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2485625552","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485625552?lang=en_us&edition=fundamental","pubTime":"2024-11-22 23:12","pubTimestamp":1732288320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 22, 2024 10:12 ET (15:12 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SF","IVA"],"gpt_icon":0},{"id":"2485422228","title":"Inventiva S.A reports 9M results","url":"https://stock-news.laohu8.com/highlight/detail?id=2485422228","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485422228?lang=en_us&edition=fundamental","pubTime":"2024-11-22 05:51","pubTimestamp":1732225870,"startTime":"0","endTime":"0","summary":"Inventiva S.A press release : 9M Revenue of 1.3B. As of September 30, 2024, the Company’s cash and cash equivalents amounted to 13.9 million, compared to cash and cash equivalents at 26.9 million, short-term deposit4 at 0.01 million, and long-term deposit5 at 9.0 million as of December 31, 2023. Net cash used in operating activities amounted to  million in the first nine months of 2024, compared to  million for the same period in 2023 down by 7.0% . R&D expenses, mainly driven by the development of lanifibranor in MASH/NASH, for the first nine months of 2024 amounted to 71.7 million and were down 10.0% compared to the 79.6 million for the first nine months of 2023.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4319073-inventiva-sa-reports-9m-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2485261784","title":"Inventiva’s Financial Position and Future Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=2485261784","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485261784?lang=en_us&edition=fundamental","pubTime":"2024-11-22 05:47","pubTimestamp":1732225632,"startTime":"0","endTime":"0","summary":"Inventiva (IVA) has released an update. Inventiva, a clinical-stage biopharmaceutical company, has reported a cash position of €13.9 million as of ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inventivas-financial-position-and-future-prospects?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inventivas-financial-position-and-future-prospects?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2485423913","title":"Inventiva Reports Revenues Of €1.3 Million For The First 9-Months Of 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2485423913","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485423913?lang=en_us&edition=fundamental","pubTime":"2024-11-22 05:16","pubTimestamp":1732223770,"startTime":"0","endTime":"0","summary":"Cash and cash equivalents at €13.9 million, as of September 30, 2024.Revenues of €1.3 million for the first nine months of 2024.On July 18, 2024, Inventiva issued royalty certificates for an amount of €20.1","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/42123657/inventiva-reports-revenues-of-1-3-million-for-the-first-9-months-of-2024","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVA"],"gpt_icon":0},{"id":"2485142847","title":"Inventiva reports 2024 Third Quarter Financial Information¹","url":"https://stock-news.laohu8.com/highlight/detail?id=2485142847","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485142847?lang=en_us&edition=fundamental","pubTime":"2024-11-22 05:00","pubTimestamp":1732222800,"startTime":"0","endTime":"0","summary":"Revenues of 1.3 million for the first nine months of 2024.On July 18, 2024, Inventiva issued royalty certificates for an amount of 20.1 million.As of September 30, 2024, the Company’s cash and cash equivalents amounted to 13.9 million, compared to cash and cash equivalents at 26.9 million, short-term deposit4 at 0.01 million, and long-term deposit5 at 9.0 million as of December 31, 2023.Net cash generated from investing activities for the first nine months of 2024 amounted to 8.7 million, compared to (3.5) million used for the same period in 2023. The change is mostly due to the variation in term deposits between both periods.Net cash generated from financing activities for the first nine months of 2024 amounted to 42.3 mi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XY_QbwknG0g_dMiiDPyLvw--~B/aD0xNzg7dz0zNzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a1497e6e1366ecc45a71fef2ce2e7535","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XY_QbwknG0g_dMiiDPyLvw--~B/aD0xNzg7dz0zNzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a1497e6e1366ecc45a71fef2ce2e7535"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inventiva-reports-2024-third-quarter-210000492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4134","III","IVA","BK4139"],"gpt_icon":0},{"id":"2485171270","title":"Inventiva Reports Voting Rights and Advances Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2485171270","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485171270?lang=en_us&edition=fundamental","pubTime":"2024-11-21 05:54","pubTimestamp":1732139694,"startTime":"0","endTime":"0","summary":"Inventiva (IVA) has released an update. Inventiva, a clinical-stage biopharmaceutical company, has reported its total voting rights and shares form...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inventiva-reports-voting-rights-and-advances-clinical-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inventiva-reports-voting-rights-and-advances-clinical-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2485171268","title":"Inventiva Prepares for Key General Meeting and Financing Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2485171268","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485171268?lang=en_us&edition=fundamental","pubTime":"2024-11-21 05:54","pubTimestamp":1732139684,"startTime":"0","endTime":"0","summary":"Inventiva (IVA) has released an update. Inventiva is gearing up for its Combined General Meeting on December 11, 2024, where shareholders will vote...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inventiva-prepares-for-key-general-meeting-and-financing-plans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inventiva-prepares-for-key-general-meeting-and-financing-plans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2485654173","title":"Statement of total voting rights and shares forming the company’s share capital as of November 4, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2485654173","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485654173?lang=en_us&edition=fundamental","pubTime":"2024-11-21 05:00","pubTimestamp":1732136400,"startTime":"0","endTime":"0","summary":"The total number of gross  voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.The total number of net  voting rights is calculated without taking into account shares for which voting rights have been suspended, i.e. treasury shares . It is released in order to ensure that the public is properly informed.The Company has a scientific team of approximately 90 people with deep expertise in the fields of biology, medicinal and computational chemistry, pharmacokinetics and pharmacology, and clinical development. It owns an extensive library of approximately 240,000 pharmacologically relevant molecules, approximately 60% of which are proprietary, as well as a wholly-owned research and development facility.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XY_QbwknG0g_dMiiDPyLvw--~B/aD0xNzg7dz0zNzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a1497e6e1366ecc45a71fef2ce2e7535","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XY_QbwknG0g_dMiiDPyLvw--~B/aD0xNzg7dz0zNzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/a1497e6e1366ecc45a71fef2ce2e7535"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/statement-total-voting-rights-shares-210000892.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2485125795","title":"Five9, Inc (FIVN) Expands AI Suite: Next-Gen AI Agents Revolutionize Customer Experience","url":"https://stock-news.laohu8.com/highlight/detail?id=2485125795","media":"Insider Monkey","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485125795?lang=en_us&edition=fundamental","pubTime":"2024-11-21 01:52","pubTimestamp":1732125122,"startTime":"0","endTime":"0","summary":"We recently published a list of 15 AI News Stories Shaking Up Wall Street. In this article, we are going to take a look at where Five9, Inc.  stands against other AI news stories shaking up Wall Street.U.S. President Joe Biden met with China’s President Xi Jinping at the APEC Summit in Lima, Peru, on November 16. According to the White House, the two reached an agreement affirming that human beings, not artificial intelligence, should make decisions about the use of nuclear weapons.“The two leaders affirmed the need to maintain human control over the decision to use nuclear weapons. The two leaders also stressed the need to consider carefully the potential risks and develop AI technology in the military field in a prudent and responsible manner”.READ ALSO: 15 AI News You Must Read Todayand15 AI News That Broke The Internet. This agreement marks a groundbreaking step in addressing two complex and challenging topics: nuclear weapons and artificial intelligence. However, it remains unclea","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Ad.yZHMd4u34PqFQ7LE_Pw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/3f9695b288b943dc1be35cb72c415c03","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Ad.yZHMd4u34PqFQ7LE_Pw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/3f9695b288b943dc1be35cb72c415c03"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/five9-inc-fivn-expands-ai-175202875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4139","BK4097","TQQQ","QLD","GEN","PSQ","MNQmain","QID","BK4023","IVA","FIVN","NQmain","SQQQ",".IXIC","LU2286300806.USD","BK4588"],"gpt_icon":1},{"id":"2484944773","title":"Travel Services Company Deploys Verint AI-Powered Self-Service, Driving $10 Million Annual Savings","url":"https://stock-news.laohu8.com/highlight/detail?id=2484944773","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484944773?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:30","pubTimestamp":1732023000,"startTime":"0","endTime":"0","summary":"Verint Intelligent Virtual Assistant Increases Containment from 10% to 50% in One Month. MELVILLE, N.Y., November 19, 2024----Verint , The CX Automation Company, today announced that a major U.S. travel services company deployed Verint AI-powered Intelligent Voice Assistant  to replace their legacy telephony IVR  solution and achieved strong AI business outcomes. The company increased containment in self-service from 10% to 50% of their telephony traffic within the first month, driving $10 million in annual savings.The company was using a legacy touch-tone IVR for self-service across 4 million calls annually. Verint IVA delivered best-of-breed intent recognition as well as integrations to back-end systems, such as CRM and location services, to accurately respond to customer questions. As a result, call containment within the self-service channel significantly increased.\"Verint IVA is revolutionizing the approach to telephony self-service,\" says Verint’s Heather Richards, vice president","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/sNjhgoZqqAzFYudgM_WcAQ--~B/aD0zOTA7dz0xNTAxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/4a5a22418c8d69382c1b590852c8297c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/sNjhgoZqqAzFYudgM_WcAQ--~B/aD0zOTA7dz0xNTAxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/4a5a22418c8d69382c1b590852c8297c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/travel-services-company-deploys-verint-133000457.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1559883803.SGD","BK4139","IVA","CX","LU0566484027.USD","BK4023","VRNT","BK4011"],"gpt_icon":1},{"id":"2484367186","title":"Alight to Enhance the Employee Experience with Launch of Alight Worklife® on Microsoft Teams","url":"https://stock-news.laohu8.com/highlight/detail?id=2484367186","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484367186?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:30","pubTimestamp":1731936600,"startTime":"0","endTime":"0","summary":"Alight’s new Teams integration, developed in collaboration with Avanade, enables employers to deliver a seamless, connected employee experience. CHICAGO, November 18, 2024----Alight, Inc. , a leading cloud-based human capital and technology-enabled services provider and Avanade, a leading Microsoft expert, today announced a collaboration to integrate Alight Worklife  with Microsoft Teams. This novel integration empowers employers to further enhance their employee’s benefits experience by providing seamless access to benefits and wellbeing information directly within the Teams platform.The application will be available to employers who utilize both Teams and Alight Worklife, beginning with the next release of the Alight Worklife platform. By integrating benefits access directly into employees’ daily software, the Alight Worklife integration for Teams will simplify benefits access, boost awareness, enable greater utilization, and enhance the overall employee experience and wellbeing.Inte","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/X6BqZ_SluYU4pjOr9PJPJA--~B/aD0yNzU7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f9646de7db226fb2e167259048d0e140","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/X6BqZ_SluYU4pjOr9PJPJA--~B/aD0yNzU7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f9646de7db226fb2e167259048d0e140"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alight-enhance-employee-experience-launch-133000677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4538","BK4130","LU1366333091.USD","IE000ITXATA3.USD","LU2125154778.USD","LU1814569148.SGD","LU0006306889.USD","LU1582987597.SGD","LU2362541513.USD","LU1934455277.USD","LU2237443895.HKD","LU0057025933.USD","IE00BMPRXQ63.HKD","IVA","IE00BFXG0V08.USD","LU1280957306.USD","GRO","LU0784383803.USD","LU2452424414.USD","MSFT","LU0757359368.USD","LU2089284900.SGD","LU2463028550.USD","LU1815333072.USD","LU1989763005.USD","LU2403377893.USD","LU1340139317.AUD","LU0795875086.SGD","IE00BK4W5M84.HKD","GB00B4QBRK32.GBP","SG9999004303.SGD","LU0081259029.USD","LU0170899867.USD","ALIT","IE00BLSP4452.SGD","LU0095938881.EUR","LU1564329032.USD","LU2404859667.USD","LU2362540622.SGD","LU2430703178.SGD","IE00BN8TJ469.HKD","LU1564329115.USD","IE0004091025.USD","LU1934455863.HKD","BK4139","LU0957791311.USD","LU0171293334.USD","LU0784385170.HKD","SG9999014880.SGD","GB00BDT5M118.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://inventivapharma.com","stockEarnings":[{"period":"1week","weight":-0.0408},{"period":"1month","weight":-0.1423},{"period":"3month","weight":0.1463},{"period":"6month","weight":-0.1199},{"period":"1year","weight":-0.4573},{"period":"ytd","weight":-0.4796}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.033773},{"month":2,"riseRate":0.5,"avgChangeRate":-0.02424},{"month":3,"riseRate":0,"avgChangeRate":-0.114231},{"month":4,"riseRate":0,"avgChangeRate":-0.166714},{"month":5,"riseRate":0.75,"avgChangeRate":0.155722},{"month":6,"riseRate":0.25,"avgChangeRate":-0.133608},{"month":7,"riseRate":0.25,"avgChangeRate":-0.09757},{"month":8,"riseRate":0.2,"avgChangeRate":0.009571},{"month":9,"riseRate":0.4,"avgChangeRate":-0.030876},{"month":10,"riseRate":0.8,"avgChangeRate":0.137564},{"month":11,"riseRate":0.2,"avgChangeRate":-0.027915},{"month":12,"riseRate":0.8,"avgChangeRate":0.038035}],"exchange":"NASDAQ","name":"Inventiva S.A.","nameEN":"Inventiva S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inventiva S.A.(IVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Inventiva S.A.(IVA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Inventiva S.A.,IVA,Inventiva S.A.股票,Inventiva S.A.股票老虎,Inventiva S.A.股票老虎国际,Inventiva S.A.行情,Inventiva S.A.股票行情,Inventiva S.A.股价,Inventiva S.A.股市,Inventiva S.A.股票价格,Inventiva S.A.股票交易,Inventiva S.A.股票购买,Inventiva S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inventiva S.A.(IVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Inventiva S.A.(IVA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction